Communication Bridge 3 Study
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Chicago
- Study ID
- NCT06191198
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Primary Progressive Aphasia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- Communication Bridge™ — BEHAVIORALEvidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.
- Evidence-Based Impairment Focused — BEHAVIORALEvidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.
Study Details
This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.
Key Dates
- Start date
- Aug 23, 2024
- Status verified
- May 2026
- Primary completion
- Jul 15, 2028
- Completion
- Jul 15, 2028
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Communication Bridge™Participants receive Communication Bridge™, a multi-component, participation-focused, dyadic intervention in which both the person with PPA and their co-enrolled communication partner are intervention recipients. Communication Bridge™ is modelled on the Living with Aphasia: Framework for Outcome Measurement (A-FROM) and the Care Pathway Model that was developed for persons living with primary progressive aphasia. Consistent with participation-focused intervention models personally salient training stimuli are incorporated into all therapy activities in the Experimental arm.
- Active Comparator: Evidence-Based Impairment FocusedThe Control arm includes a non-dyadic intervention in which the person with PPA is the active intervention recipient and their communication partner is in a supporting role. In the Control arm, participants receive a speech-language intervention designed to address impairment and functional limitations, comprised of activities that address word retrieval and 'automatic' speech production using fixed, non-personalized, stimuli across participants.
Primary Outcome Measure
Change in Communication Participation Person Centered Goals [ Time Frame: 5 assessment time points through study completion (up to 18 months) ]
Central Contacts
- Matthew Bona, MPH773-702-1220
- Emily Cummings773-702-1221
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Chicago - American School Building | Chicago | Illinois | 60637 | Matthew Bona, MPH |
Find similar trials in Chicago, IL
By research site
Related Studies
- Language in Primary Progressive AphasiaRecruiting · Northwestern University · Chicago, Illinois
- Longitudinal Multi-Modality Imaging in Progressive Apraxia of SpeechPHASE4 · Recruiting · Mayo Clinic · Rochester, Minnesota
- The Neurobiology of Two Distinct Types of Progressive Apraxia of SpeechRecruiting · Mayo Clinic · Rochester, Minnesota
- Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPARecruiting · Johns Hopkins University · Baltimore, Maryland